I'm waiting for the true significance of today to actually sink in to many minds.....Ryoncil /Remestemcel L same treatment... just got endorsed by a 9 -1 margin by peers and is millimetres away from 1st FDA approval .....so folks who haven't looked close enough ...I invite you to make the connection as it's right there staring at you in the face.Today was crucial not just for MSB but also for FDA in moving towards that second goal ...and that won't be far behind. So if it works for one ....
From MSB's quarterly update July 30th ....
http://investorsmedia.mesoblast.com/static-files/fcaaa910-999c-4f56-9b44-68c01e3b17cf
"Mesoblast Chief Executive Dr Silviu Itescu stated: “Remestemcel-L has two imminent majormilestones, the interim analysis in the ongoing Phase 3 trial of remestemcel-L in COVID-19 patientswith acute respiratory distress syndrome and the FDA advisory committee panel review of oursubmission for potential approval of RYONCIL™ (remestemcel-L) in children with steroid-refractoryacute graft versus host disease."
MSB Trading 2020 - a new dawn, page-429
-
- There are more pages in this discussion • 12,642 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.030(3.13%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | $1.03 | 96.5¢ | $4.704M | 4.708M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 87395 | 98.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 274051 | 2 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |